Dyax falls on DX-88 delay

Dyax (NASDAQ:DYAX) fell $0.41 (11%) to $3.35 on Monday after it said the planned closure of its clinical research provider, BattelleCRO

Read the full 211 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE